Comparison of gliclazide vs linagliptin on hypoglycemia and cardiovascular events in type 2 diabetes mellitus: A systematic review

doi:10.4239/wjd.v13.i12.1168

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6161)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

278

WORD

HTML

4378

Figures (1-1)

338

Tables (1-3)

303

Sum=5356

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

239

Download

528

Sum=767

Dec 15, 2022 (publication date) through Nov 16, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Systematic Reviews

World J Diabetes. Dec 15, 2022; 13(12): 1168-1183
Published online Dec 15, 2022. doi: 10.4239/wjd.v13.i12.1168

Full Size Figure Download Figure

Figure 1 Preferred Reporting Items for Systematic Reviews and Meta-Analyses flow chart of literature search and selection. AE: Adverse event; DPP4: Dipeptidyl peptidase 4; GLD: Glucose-lowering drug; MA: Meta-analysis; PBO: Placebo; PD: Pharmacodynamic; PK: Pharmacokinetic; PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses; RCT: Randomized controlled trials; SR: Systematic review; SU: Sulfonylurea.

Citation: Mohan V, Wangnoo S, Das S, Dhediya R, Gaurav K. Comparison of gliclazide vs linagliptin on hypoglycemia and cardiovascular events in type 2 diabetes mellitus: A systematic review. World J Diabetes 2022; 13(12): 1168-1183
URL: https://www.wjgnet.com/1948-9358/full/v13/i12/1168.htm
DOI: https://dx.doi.org/10.4239/wjd.v13.i12.1168